Corneal Myofibroblasts Suppress T-Cell Immunity in Corneal Transplantation
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.15.2 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Shudan Wang and 10 co-authors. Institution: Cornea Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States. Major MEDLINE topics: Myofibroblasts, Corneal Transplantation, Cornea, T-Lymphocytes. 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.
Abstract (original language)
Purpose
To evaluate the immunoregulatory effect of corneal myofibroblasts on effector T cells derived from allogeneic corneal transplant recipient mice.
Methods
Allo-primed CD4+CD25- effector T cells isolated from the draining lymph nodes of corneal transplant recipient mice were cocultured with corneal myofibroblasts or corneal fibroblasts. Flow cytometry was used to measure effector T-cell activation and function by expression of CD69, CD40L, and IFN-γ. Flow cytometry was also used to quantify T-cell apoptosis and T-cell proliferation upon coculture with corneal myofibroblasts.
Results
Coculturing effector T cells with corneal myofibroblasts led to a significant decrease in effector T-cell activation as assessed by T-cell expression of CD69 (5520 ± 373 vs. 1701 ± 140) and CD40L (127.50 ± 4.17 vs. 42.87 ± 2.63) mean fluorescence intensity; this suppression was not seen with corneal fibroblasts. Coculture of T cells with myofibroblasts additionally led to a significant reduction in the frequency of IFN-γ+ effector T cells compared to coculture with fibroblasts (2.94% ± 0.85% vs. 0.65% ± 0.23%). Finally, compared to fibroblasts, coculture with myofibroblasts led to a significant increase in the frequency of apoptotic effector T cells (14.78% ± 3.67% vs. 32.48% ± 5.43%) and a significant reduction in T-cell proliferation (61.60% ± 2.68% vs. 39.63% ± 0.92%).
Conclusions
Myofibroblasts are capable of suppressing T-cell immunity through suppression of effector T-cell proliferation, activation, and function, as well as the promotion of T-cell apoptosis. Our data suggest that in addition to their well-established role in extracellular matrix production, myofibroblasts may also actively participate in immunoregulation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Cornea Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States.
Funding
- NEI NIH HHS
Cite
APA
Wang, S., Esquivel Herrera, A., Elbasiony, E., Lee, S., Mittal, S. K., Dehghani, S., Narimatsu, A., Alemi, H., Chauhan, S. K., Dana, R., & Dohlman, T. H. (2025). Corneal Myofibroblasts Suppress T-Cell Immunity in Corneal Transplantation. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.15.2
Vancouver
Wang S, Esquivel Herrera A, Elbasiony E, Lee S, Mittal SK, Dehghani S, et al. Corneal Myofibroblasts Suppress T-Cell Immunity in Corneal Transplantation. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.15.2
BibTeX
@article{Wang2025,
author = {Wang, Shudan and Esquivel Herrera, Antonio and Elbasiony, Elsayed and Lee, Seokjoo and Mittal, Sharad K and Dehghani, Shima and Narimatsu, Akitomo and Alemi, Hamid and Chauhan, Sunil K and Dana, Reza and Dohlman, Thomas H},
title = {Corneal Myofibroblasts Suppress T-Cell Immunity in Corneal Transplantation},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.15.2}
}
EUVIMED